Arcutis Biotherapeutics, Inc.
2022 Q1 - 2025 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 286,756 | 7.7% | 9,874,511 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 186,135 | 5.6% | 9,874,511 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 138,441 | 5.5% | 9,874,511 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 137,402 | 6.3% | 8,785,284 | 3/31/2025 |
| 2024 Q4 | 2/18/2025 | 122,379 | 5.1% | 8,785,284 | 12/31/2024 |
| 2024 Q3 | 11/15/2024 | 81,703 | 3.3% | 8,785,284 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 81,703 | 3.8% | 8,785,284 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 87,062 | 3.7% | 8,785,284 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 28,308 | 1.5% | 8,764,232 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 46,113 | 3.1% | 8,684,232 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 82,761 | 4.9% | 8,684,232 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 95,527 | 6.9% | 8,684,232 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 128,527 | 8.0% | 8,684,232 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 165,956 | 13% | 8,684,232 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 179,733 | 17% | 8,434,232 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 162,443 | 14% | 8,434,232 | 3/31/2022 |